These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4479573)

  • 21. Editorial: Vasodilator therapy of myocardial infarction.
    Cohn JN
    N Engl J Med; 1974 Jun; 290(25):1433-4. PubMed ID: 4208373
    [No Abstract]   [Full Text] [Related]  

  • 22. Low doses of inhaled nitric oxide in heart transplant recipients.
    Auler Júnior JO; Carmona MJ; Bocchi EA; Bacal F; Fiorelli AI; Stolf NA; Jatene AD
    J Heart Lung Transplant; 1996 May; 15(5):443-50. PubMed ID: 8771498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced systemic vascular resistance as therapy for severe mitral regurgitation of valvular origin.
    Harshaw CW; Grossman W; Munro AB; McLaurin LP
    Ann Intern Med; 1975 Sep; 83(3):312-6. PubMed ID: 1180426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitral regurgitation: physiologic, clinical and surgical considerations.
    Braunwald E
    N Engl J Med; 1969 Aug; 281(8):425-33. PubMed ID: 5797187
    [No Abstract]   [Full Text] [Related]  

  • 25. Haemodynamic effects of glucagon after mitral valve replacement.
    Smith GH; Chandra K
    Thorax; 1972 Sep; 27(5):591-3. PubMed ID: 4563399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemodynamic changes in the early postoperative period in patients after surgery for mitral insufficiency using extracorporeal circulation].
    Lisetskiĭ VA; Nikishin LF
    Kardiologiia; 1969 May; 9(5):45-9. PubMed ID: 5805775
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of peri-operative pulmonary hypertension in a patient presenting for a portosystemic shunt.
    Kinirons B; Kuhlman L; Mori K; Samii K
    Eur J Anaesthesiol; 1999 Oct; 16(10):728-32. PubMed ID: 10583358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension.
    Curran RD; Mavroudis C; Backer CL; Sautel M; Zales VR; Wessel DL
    Ann Thorac Surg; 1995 Dec; 60(6):1765-71. PubMed ID: 8787478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mitral valve regurgitation associated with severe pulmonary hypertension successfully treated with nitric oxide gas: report of a case].
    Hamamoto H; Yamauchi H; Yamaguchi H; Hazama S
    Kyobu Geka; 2000 May; 53(5):384-6. PubMed ID: 10808287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of the hemodynamic effects of intravenous Trinitrine. Applications to the vasodilator treatment of heart failure, myocardial infarct, and mitral insufficiency].
    Baligadoo S; Ingrand JC; Derrida JP; Savier CH; Chiche P
    Coeur Med Interne; 1978; 17(2):231-42. PubMed ID: 95918
    [No Abstract]   [Full Text] [Related]  

  • 31. Effective control of refractory pulmonary hypertension after cardiac operations.
    Fullerton DA; Jaggers J; Piedalue F; Grover FL; McIntyre RC
    J Thorac Cardiovasc Surg; 1997 Feb; 113(2):363-8; discussion 368-70. PubMed ID: 9040631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
    Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled NO and sildenafil combination in cardiac surgery patients with out-of-proportion pulmonary hypertension: acute effects on postoperative gas exchange and hemodynamics.
    Matamis D; Pampori S; Papathanasiou A; Papakonstantinou P; Tsagourias M; Galiatsou E; Koulouras V; Nakos G
    Circ Heart Fail; 2012 Jan; 5(1):47-53. PubMed ID: 22057829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury.
    Jacobs BR; Brilli RJ; Ballard ET; Passerini DJ; Smith DJ
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1536-42. PubMed ID: 9817705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of vasodilators in treating cardiac insufficiency].
    Malamov E
    Vutr Boles; 1980; 19(5):10-5. PubMed ID: 7003916
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effects of inhaled nitric oxide on pulmonary vascular resistance in patients after total cavopulmonary connection].
    Yin ZT; Zhu HY; Zhang RF; Zhang NB; Wang ZW; Gong HD; Wang J; Song HC
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):647-9. PubMed ID: 16008934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indications, modifications and technique of ECMO with or without NO-therapy.
    Pappert D; Falke KJ
    Acta Anaesthesiol Scand Suppl; 1996; 109():117-20. PubMed ID: 8901974
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of inhaled nitric oxide versus oxygen on hemodynamics in patients with mitral stenosis and severe pulmonary hypertension after mitral valve surgery.
    Fernandes JL; Sampaio RO; Brandão CM; Accorsi TA; Cardoso LF; Spina GS; Tarasoutchi F; Pomerantzeff P; Auler JO; Grinberg M
    Am J Cardiol; 2011 Apr; 107(7):1040-5. PubMed ID: 21296315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manual on cardiac catheterization in adults with acquired and congenital heart disease.
    Ramsey HW; Barrow MV; Williams JC
    Mod Treat; 1972 May; 9(2):323-53. PubMed ID: 4563490
    [No Abstract]   [Full Text] [Related]  

  • 40. Beneficial effects of hydralazine in severe mitral regurgitation.
    Greenberg BH; Massie BM; Brundage BH; Botvinick EH; Parmley WW; Chatterjee K
    Circulation; 1978 Aug; 58(2):273-9. PubMed ID: 668075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.